This Friday, April 1, the National Ministry of Health reported the detection of 1,927 new cases of coronavirus in all the country, a reduction of 700 infections compared to the previous day. This drop caused the daily positivity rate in Argentina to be 8%, after carrying out 27,993 swabs.
In addition, In the last 24 hours, some 34 deaths associated with the coronavirus in all the country, 17 of them corresponded to women and 17 to men. deaths from viral disease they accumulated in the provinces of Buenos Aires, CABA and Tucumán.
On this day, all jurisdictions in the country reported new infections of coronavirus. The list of cases was distributed as follows: Province of Buenos Aires (826), CABA (339), Córdoba (185) and Misiones (165).
They are followed, with less than 100 daily infections, by Santa Fe (94), Chubut (51), Río Negro (43), Mendoza (36), Entre Ríos (33), San Luis (29), La Pampa (26), Neuquén (26), Santa Cruz (17), Formosa (11), Tucumán (11), San Juan (10), Chaco (6), Salta (6), Catamarca (4), Corrientes (2), La Rioja ( 2), Santiago del Estero (2), Tierra del Fuego (2) and Jujuy (1).
On the other hand, the number of patients with active cases of coronavirus in Argentina, that is, those who currently carry the disease, dropped today to 48,012 people, of which 487 required hospitalization in the country’s Intensive Care Units. This places the hospital occupancy rate at 37.9% at the national level and 38.9% in the AMBA.
However, since the arrival of the pandemic of the coronavirus to Argentina, a little over two years ago, the country’s health authorities have identified 9,039,838 cases and 128,052 deaths related in respiratory infectionone of the highest rates in the entire Latin American region.
Strategic Vaccination Plan
Until the cutoff at 5:00 p.m., a total of 96,811,034 vaccines had been applied against coronavirus throughout the Argentine territory, of the 104,147,164 doses distributed since the start of the campaign, in December 2019.
Specifically, some 40,621,760 Argentine men and women received the first dose of the inoculant drugs, 36,983,330 people completed the scheme with both guidelines and 16,178,468 people reinforced the scheme with a third booster vaccine, this according to data from the Public Monitor of Vaccination.